New York, NY -- (SBWire) -- 10/14/2020 --The global radiopharmaceuticals/Nuclear Medicine Market is growing at a significant CAGR due to rising in the prevalence of various types of cancers and cardiovascular diseases. The growing prevalence of various cancers resulted in an increased adoption of radiopharmaceuticals in diagnosis and treatment of several cancers in developed economies. For instance, according to globocan cancer statistics, There were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 worldwide. Moreover, advances in technology such as introduction of PET radiotracers and targeted radioimmunotherapies expected to drive the overall market revenue growth over the forecast period.
Major Key Players of the Radiopharmaceuticals-Nuclear Medicine Market are:
Advanced Accelerator Applications S.A. (France), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Cardinal Health, Inc. (U.S.), Eli Lilly and Co. (U.S.), GE Healthcare (U.S.), BA Molecular Imaging (Belgium), Jubilant Life Sciences Ltd (India), Lantheus Medical Imaging, Inc. (U.S.), Mallinckrodt plc (Ireland), Navidea Biopharmaceutical (U.S.), Nordion, Inc. (Canada), Siemens Healthineers (Germany)
Get sample copy of "Radiopharmaceuticals-Nuclear Medicine Market" at: https://bit.ly/33X7pbN
The development of effective radiopharmaceuticals for diagnosis and treatment expected to drive the market revenue growth over the forecast period. The advances in imaging devices with radio-activity are aiding healthcare professionals in effective diagnosis. Moreover, radio-imaging diagnosis is considered as an effective alternative to the conventional diagnosis techniques such as X-rays which expected to boost the market demand for diagnostic radiopharmaceuticals across the globe. In addition, increase in the healthcare expenditure, radiopharmaceuticals abundance, and non-invasiveness in the treatment and diagnostic procedure might bolster the nuclear medicine market over the forecast period.
Major Types of Radiopharmaceuticals-Nuclear Medicine Market covered are:
Diagnostic Radiopharmaceuticals
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Beta Emitters
Alpha emitters
Brachytherapy
Others
Major Applications of Radiopharmaceuticals-Nuclear Medicine Market covered are:
Oncology
Neurological disorders
Cardiovascular diseases
Thyroid
Others
Research objectives:-
– To study and analyze the global Radiopharmaceuticals-Nuclear Medicine consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the Radiopharmaceuticals-Nuclear Medicine market by identifying its various sub-segments.
– Focuses on the key global Radiopharmaceuticals-Nuclear Medicine manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Radiopharmaceuticals-Nuclear Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Go For Interesting Discount Here: https://bit.ly/318QK38
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Radiopharmaceuticals-Nuclear Medicine Market Size
2.2 Radiopharmaceuticals-Nuclear Medicine Growth Trends by Regions
2.3 Industry Trends
3 Market Share by Key Players
3.1 Radiopharmaceuticals-Nuclear Medicine Market Size by Manufacturers
3.2 Radiopharmaceuticals-Nuclear Medicine Key Players Head office and Area Served
3.3 Key Players Radiopharmaceuticals-Nuclear Medicine Product/Solution/Service
3.4 Date of Enter into Radiopharmaceuticals-Nuclear Medicine Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Radiopharmaceuticals-Nuclear Medicine Sales by Product
4.2 Global Radiopharmaceuticals-Nuclear Medicine Revenue by Product
4.3 Radiopharmaceuticals-Nuclear Medicine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Radiopharmaceuticals-Nuclear Medicine Breakdown Data by End User
Have any query? Inquiry about report at: https://bit.ly/3iTqKP3
In the end, Radiopharmaceuticals-Nuclear Medicine industry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, and market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.
About Market Growth Insight
Market Growth Insight 100% Subsidiary of Exltech Solutions India, is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 30000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends.
Contact Us-
Email: sales@marketgrowthinsight.com
Phone: + 91 8956767535
Website: https://www.marketgrowthinsight.com
Nuclear Medicine Market to Witness Robust Expansion by 2025 with Prominent Key Players: Bayer AG (Germany), Bracco Imaging S.p.A (Italy)
Global nuclear medicine Market estimated to be valued US$ 5,146 Mn in 2018 and poised to grow at CAGR of 8.9% over 2019-2025. Market for nuclear medicine Market projected to reach US$ 8,564 Mn by 2025 owing to increasing adoption in radio therapeutic and diagnostic procedures across the globe.